TD Asset Management
NKTR icon

TD Asset Management’s Nektar Therapeutics NKTR Stock Holding History

TD Asset Management’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-2,680
Closed -$667K – 1460
2020
Q3 		$667K Hold
2,680
– – ﹤0.01% 1178
2020
Q2 		$931K Sell
2,680
-173
-6% -$54K ﹤0.01% 1077
2020
Q1 		$764K Buy
2,853
+1,053
+59% +$326K ﹤0.01% 1065
2019
Q4 		$583K Sell
1,800
-3,641
-67% -$1.06M ﹤0.01% 1211
2019
Q3 		$1.49M Buy
5,441
+340
+7% +$125K ﹤0.01% 979
2019
Q2 		$2.72M Sell
5,101
-515
-9% -$258K ﹤0.01% 845
2019
Q1 		$2.83M Buy
5,616
+28
+0.5% +$16.6K ﹤0.01% 832
2018
Q4 		$2.75M Sell
5,588
-353
-6% -$213K ﹤0.01% 833
2018
Q3 		$5.43M Sell
5,941
-372
-6% -$318K 0.01% 703
2018
Q2 		$4.62M Sell
6,313
-2,195
-26% -$2.53M 0.01% 734
2018
Q1 		$13.6M Buy
8,508
+6,988
+460% +$9M 0.02% 456
2017
Q4 		$1.36M Buy
+1,520
New +$899K ﹤0.01% 971
2017
Q2 		– Sell
-1,087
Closed -$383K – 1356
2017
Q1 		$383K Sell
1,087
-106
-9% -$23.8K ﹤0.01% 1274
2016
Q4 		$220K Sell
1,193
-14
-1% -$2.85K ﹤0.01% 1331
2016
Q3 		$311K Buy
+1,207
New +$311K ﹤0.01% 1294
2014
Q2 		– Sell
-1,267
Closed -$230K – 1305
2014
Q1 		$230K Hold
1,267
– – ﹤0.01% 1212
2013
Q4 		$216K Buy
1,267
+127
+11% +$20.5K ﹤0.01% 1216
2013
Q3 		$179K Hold
1,140
– – ﹤0.01% 1211
2013
Q2 		$198K Buy
+1,140
New +$175K ﹤0.01% 1135

Other funds holding NKTR

Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

TD Asset Management's NKTR Position: Q4 2020 in Review

TD Asset Management sold out of Nektar Therapeutics (NKTR) in Q4 2020, closing a stake of 2,680 shares — an estimated $667K sold.

TD Asset Management first reported a position in NKTR in Q2 2013 and held it in 19 quarters. The position peaked at $13.6M in Q1 2018. 245 funds tracked by Wall St. Rank hold NKTR as of Q4 2020.

  • TD Asset Management reported no remaining Nektar Therapeutics position as of Q4 2020 after selling out during the quarter.
  • TD Asset Management sold 2,680 Nektar Therapeutics shares in Q4 2020, an estimated $667K.
  • TD Asset Management first reported a position in Nektar Therapeutics in Q2 2013 and held it in 19 quarters.
  • TD Asset Management's Nektar Therapeutics position peaked at $13.6M in Q1 2018.
  • 245 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q4 2020.

Based on TD Asset Management's 13F filing for Q4 2020, filed 16 Feb 2021.